Incorporation of camptothecin into reduction-degradable supramolecular micelles for enhancing its stability

Colloids and Surfaces B: Biointerfaces

Volumn 109, Issue , 2013, Pages 167-175

  Luo, Ping ^a   Luo, Yu ^a   Huang, Jin ^a,b   Lu, Wei ^a   Luo, Dajun ^c   Yu, Jiahui ^a   Liu, Shiyuan ^d  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b WUHAN UNIVERSITY OF TECHNOLOGY   (China)

^c Xishan Institute of Biotechnology   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Camptothecin; Cytotoxicity; Reduced degradability; Stability; Supramolecular micelles

Indexed keywords

CAMPTOTHECIN (CPT); DEGRADABILITY; DELIVERY SYSTEMS; MICHAEL ADDITION POLYMERIZATION; PASSIVE TARGETING; PHYSIOLOGICAL CONDITION; POLYETHYLENE GLYCOL MONOMETHYL ETHER; SUPRAMOLECULAR MICELLES;

ADDITION REACTIONS; BODY FLUIDS; CELL CULTURE; CONVERGENCE OF NUMERICAL METHODS; CYTOTOXICITY; DIALYSIS; MOTION PICTURE EXPERTS GROUP STANDARDS; STABILITY; SUPRAMOLECULAR CHEMISTRY; TUMORS;

MICELLES;

BETA CYCLODEXTRIN DERIVATIVE; CAMPTOTHECIN; CYSTAMINE; DITHIOTHREITOL;

ANIMAL CELL; ARTICLE; BIODEGRADABILITY; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DIALYSIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; HYDROLYSIS; HYDROPHOBICITY; IN VITRO STUDY; MICELLE; MICHAEL ADDITION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; SUPRAMOLECULAR MICELLE; SYNTHESIS;

ANIMALS; CAMPTOTHECIN; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; MACROMOLECULAR SUBSTANCES; MICE; MICELLES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PARTICLE SIZE; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES;

EID: 84877333946     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.03.048     Document Type: Article

References (52)

1. Bajpai A.K., Shukla S.K., Bhanu S., et al. Prog. Polym. Sci. 2008, 33:1088.
2. Rapoport N. Prog. Polym. Sci. 2007, 32:962.
3. Wei H., Cheng S.X., Zhang X.Z., et al. Prog. Polym. Sci. 2009, 34:893.
4. Meng F., Hennink W.E., Zhong Z. Biomaterials 2009, 30:2180.
5. Gabizon A.A., Tzemach D., Horowitz A.T., et al. Clin. Cancer Res. 2006, 12:1913.
6. Cuchelkar Vaikunth P.K., Kopecek J. Macromol. Biosci. 2008, 8:375.
7. Oh J.K., Siegwart D.J., Matyjaszewski K. J. Am. Chem. Soc. 2007, 129:5939.
8. Oh J.K., Siegwart D.J., Matyjaszewski K. Biomacromolecules 2007, 8:3326.
9. Sun H., Guo B., Cheng R., et al. Biomaterials 2009, 30:6358.
10. Xu Y., Meng F., Cheng R., et al. Macromol. Biosci. 2009, 9:1254.
11. Guo Q., Luo P., Luo Y., et al. Colloids Surf. B: Biointerfaces 2012, 100:138.
12. Zhang X.Z., Du F., Huang J., et al. Colloids Surf. B: Biointerfaces 2012, 100:155.
13. Cheng R., Feng F., Meng F.H., et al. J. Control. Release 2011, 152:2.
14. Hsiang Y.H., Hertzberg R., Hecht S., et al. J. Biol. Chem. 1985, 260:14873.
15. Jaxel C., Kohn K.W., Wani M.C., et al. Cancer Res. 1989, 49:1465.
16. Kingsbury W., Boehm J., Jakas D., et al. J. Med. Chem. 1991, 34:98.
17. Gottlieb J.A., Guarino A.M., Call J.B. Cancer Chemother. Rep. 1970, 54:461.
18. Schaeppi U., Fleischman R.W., Cooney D.A. Cancer Chemother. Rep. 1974, 35:25.
19. Mi Z., Burke T.G. Biochemistry 1994, 33:12540.
20. Mi Z., Burke T.G. Biochemistry 1994, 33:10325.
21. Opanasopit P., Yokoyama M., Watanabe M. J. Control. Release 2005, 104:313.
22. Fassberg J., Stella V.J. J. Pharm. Sci. 1992, 81:676.
23. Hatefi A., Amsden B. Pharm. Res. 2002, 19:1389.
24. Thomas C.J., Rahier N.J., Hecht S.M. Bioorg. Med. Chem. 2004, 12:1585.
25. Venditto V.J., Simanek E.E. Mol. Pharm. 2010, 7:307.
26. Goldberg D.S., Vijayalakshmi N., Swaan P.W. J. Control. Release 2011, 150:318.
27. Lundberg B.B. Anticancer Drug Des. 1998, 13:453.
28. Liu X., Lynn B.C., Zhang J., et al. J. Am. Chem. Soc. 2002, 124:7650.
29. Ertl B., Platzer P., Wirth M., et al. J. Control. Release 1999, 61:305.
30. Kumar V., Kang J., Hohl R.J. Pharm. Dev. Technol. 2001, 6:459.
31. Tong W., Wang L., D'Souza M.J. Drug Dev. Ind. Pharm. 2003, 29:745.
32. Conover C.D., Greenwald R.B., Pendri A., et al. Anticancer Drug Des. 1999, 14:499.
33. Singer J.W., De Vries P., Bhatt R., et al. Ann. N.Y. Acad. Sci. 2000, 922:136.
34. Qiu B., Williams G.C., Sinko P., et al. J. Control. Release 2003, 91:61.
35. Dharap S.S., Wang Y., Chandna P., et al. Proc. Natl. Acad. Sci. USA 2005, 102:12962.
36. Paranjpe P.V., Stein S., Sinko P.J. Anticancer Drugs 2005, 16:763.
37. Tyner K.M., Schiffman S.R., Giannelis E.P. J. Controlled Release 2004, 95:501.
38. Opanasopit P., Yokoyama M., Watanabe M., et al. Pharm. Res. 2004, 21:2001.
39. Yokoyama M., Opanasopit P., Okano T., et al. J. Drug Target 2004, 12:373.
40. Mu L., Elbayoumi T.A., Torchilin V.P. Int. J. Pharm. 2005, 306:142.
41. Opanasopit P., Yokoyama M., Watanabe M., et al. J. Control. Release 2005, 104:313.
42. Watanabe M., Kawano K., Yokoyama M., et al. Int. J. Pharm. 2006, 308:183.
43. Maeda H., Wu J., Sawa T. J. Control. Release 2000, 65:271.
44. Emilitri E., Ranucci E., Ferruti P. J. Polym. Sci. Part A Polym. Chem. 2005, 43:404.
45. Petter R.C., Salek J.S., Sikorski C.T., et al. J. Am. Chem. Soc. 1990, 112:3860.
46. Liu Y.Y., Fan X.D., Gao L. Macromol. Biosci. 2003, 3:715.
47. David C., Hervé F., Sébille B., et al. Sens. Actuators B 2006, 114:869.
48. Zhao H., Lee C., Sai P. J. Org. Chem. 2000, 65:4601.
49. Schneider H.J., Hacket F., Rudiger V., et al. Chem. Rev. 1998, 98:1755.
50. Rudiger V., Eliseev A., Simova S., et al. J. Chem. Soc., Perkin Trans. 1996, 2:2119.
51. Jaime C., Redondo J., Sanchezferrando F., et al. J. Org. Chem. 1990, 55:4772.
52. Mo H.P., Pochapsky T.C. Prog. Nucl. Magn. Reson. Spectrosc. 1997, 30:1.